BACKGROUND: Chemerin is a newly discovered adipokine, whose circulating concentration is increased in obesity. AIM: To elucidate whether the increased circulating chemerin concentrations in obese subjects are associated with the increase of fat mass, the increase in chemerin gene expression in adipose tissue or both. MATERIAL/SUBJECTS AND METHODS: Serum chemerin concentrations in 20 non-obese healthy volunteers and 21 non-diabetic obese subjects were measured using ELISA. Chemerin mRNA and chemerin protein levels in visceral and subcutaneous adipose tissues of obese subjects were analyzed by Real-Time PCR and Western blot respectively. RESULTS: We found that the serum chemerin concentrations were significantly higher in obese subjects than in controls and positively correlated with BMI, fat mass and body mass. Moreover serum chemerin concentrations were correlated positively with serum CRP concentrations independently of BMI. No correlation was found between the chemerin mRNA and chemerin protein levels in visceral and subcutaneous adipose tissues and BMI, fat mass, or body weight. Likewise, there was no correlation between the serum chemerin concentrations and the levels of chemerin mRNA and protein in adipose tissue of obese patients. Multiple regression analysis suggests that BMI was the main predictor of serum chemerin concentration. In contrast to chemerin, both serum leptin concentrations and adipose tissue leptin mRNA levels positively correlated with BMI. CONCLUSIONS: The results presented here indicate that serum chemerin concentrations correlated with BMI, whereas chemerin mRNA levels in adipose tissue did not. Thus the elevated circulating chemerin concentration in obese, non-diabetic patients was mainly associated with the increased BMI.
BACKGROUND:Chemerin is a newly discovered adipokine, whose circulating concentration is increased in obesity. AIM: To elucidate whether the increased circulating chemerin concentrations in obese subjects are associated with the increase of fat mass, the increase in chemerin gene expression in adipose tissue or both. MATERIAL/SUBJECTS AND METHODS: Serum chemerin concentrations in 20 non-obese healthy volunteers and 21 non-diabetic obese subjects were measured using ELISA. Chemerin mRNA and chemerin protein levels in visceral and subcutaneous adipose tissues of obese subjects were analyzed by Real-Time PCR and Western blot respectively. RESULTS: We found that the serum chemerin concentrations were significantly higher in obese subjects than in controls and positively correlated with BMI, fat mass and body mass. Moreover serum chemerin concentrations were correlated positively with serum CRP concentrations independently of BMI. No correlation was found between the chemerin mRNA and chemerin protein levels in visceral and subcutaneous adipose tissues and BMI, fat mass, or body weight. Likewise, there was no correlation between the serum chemerin concentrations and the levels of chemerin mRNA and protein in adipose tissue of obesepatients. Multiple regression analysis suggests that BMI was the main predictor of serum chemerin concentration. In contrast to chemerin, both serum leptin concentrations and adipose tissue leptin mRNA levels positively correlated with BMI. CONCLUSIONS: The results presented here indicate that serum chemerin concentrations correlated with BMI, whereas chemerin mRNA levels in adipose tissue did not. Thus the elevated circulating chemerin concentration in obese, non-diabeticpatients was mainly associated with the increased BMI.
Authors: John N Fain; Balkachew M Tagele; Paramjeet Cheema; Atul K Madan; David S Tichansky Journal: Obesity (Silver Spring) Date: 2009-10-15 Impact factor: 5.002
Authors: Michael Lehrke; Alexander Becker; Martin Greif; Renee Stark; Rüdiger P Laubender; Franz von Ziegler; Corinna Lebherz; Janine Tittus; Maximilian Reiser; Christoph Becker; Burkhard Göke; Alexander W Leber; Klaus G Parhofer; Uli C Broedl Journal: Eur J Endocrinol Date: 2009-06-04 Impact factor: 6.664
Authors: Carmen Hurtado del Pozo; Rosa M Calvo; Gregorio Vesperinas-García; Javier Gómez-Ambrosi; Gema Frühbeck; Ramón Corripio-Sánchez; Miguel A Rubio; Maria-Jesus Obregon Journal: Obesity (Silver Spring) Date: 2009-10-29 Impact factor: 5.002
Authors: Johanna Weigert; Markus Neumeier; Josef Wanninger; Michael Filarsky; Sabrina Bauer; Reiner Wiest; Stefan Farkas; Marcus N Scherer; Andreas Schäffler; Charalampos Aslanidis; Jürgen Schölmerich; Christa Buechler Journal: Clin Endocrinol (Oxf) Date: 2009-06-24 Impact factor: 3.478
Authors: Bee K Tan; Jing Chen; Syed Farhatullah; Raghu Adya; Jaspreet Kaur; Dennis Heutling; Krzysztof C Lewandowski; J Paul O'Hare; Hendrik Lehnert; Harpal S Randeva Journal: Diabetes Date: 2009-06-05 Impact factor: 9.461
Authors: Emma S Darios; Brittany M Winner; Trevor Charvat; Antoni Krasinksi; Sreenivas Punna; Stephanie W Watts Journal: Am J Physiol Heart Circ Physiol Date: 2016-07-01 Impact factor: 4.733
Authors: Adriana Florinela Cătoi; Şoimiţa Suciu; Alina Elena Pârvu; Cătălin Copăescu; Romeo Florin Galea; Anca Dana Buzoianu; Ioan Andrei Vereşiu; Cornel Cătoi; Ioana Delia Pop Journal: Clujul Med Date: 2014-01-30